Allen James Meglin, Director at Organicell Regenerative Medicine, Inc. (BPSR), bought 625,000 shares at $0.08 ($50K) on 2020-10-16, disclosed to the SEC on 2020-12-09.
Open-market purchase of $50k BPSR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |